USE OF THE GONADOTROPIN-RELEASING-HORMONE AGONIST TRIPTORELIN IN THE DIAGNOSIS OF DELAYED PUBERTY IN BOYS

被引:28
|
作者
ZAMBONI, G
ANTONIAZZI, F
TATO, L
机构
来源
JOURNAL OF PEDIATRICS | 1995年 / 126卷 / 05期
关键词
D O I
10.1016/S0022-3476(95)70406-X
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
To differentiate gonadotropin deficiency from delayed puberty in teenage boys, 0.1 mg/m(2) of triptorelin, a gonadotropin-releasing hormone agonist, was administered subcutaneously at 4 AM. Serum gonadotropins and testosterone levels were determined at baseline and 4 hours after the injection. The increase in blood gonadotropin and testosterone levels was significantly greater in patients with delayed puberty than in those with gonadotropin deficiency.
引用
收藏
页码:756 / 758
页数:3
相关论文
共 50 条
  • [1] LIPOPROTEIN(A) INCREASE IN PSEUDOMENOPAUSE INDUCED BY THE GONADOTROPIN-RELEASING-HORMONE (GNRH) AGONIST TRIPTORELIN
    PINTO, S
    FEDI, S
    PANICCIA, R
    BRUNELLI, T
    BRUNI, V
    ROSATI, D
    ABBATE, R
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 881 - 881
  • [2] GONADOTROPIN-RELEASING-HORMONE AGONIST USE BEFORE HYSTERECTOMY
    STOVALL, TG
    SUMMIT, RL
    WASHBURN, SA
    LING, FW
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 170 (06) : 1744 - 1751
  • [3] Subcutaneous Gonadotropin-Releasing Hormone Agonist (Triptorelin) Test for Diagnosing Precocious Puberty
    Poomthavorn, Preamrudee
    Khlairit, Patcharin
    Mahachoklertwattana, Pat
    HORMONE RESEARCH, 2009, 72 (02) : 114 - 119
  • [4] USE OF A POTENT, LONG-ACTING AGONIST OF GONADOTROPIN-RELEASING-HORMONE IN THE TREATMENT OF PRECOCIOUS PUBERTY
    BOEPPLE, PA
    MANSFIELD, MJ
    WIERMAN, ME
    RUDLIN, CR
    BODE, HH
    CRIGLER, JF
    CRAWFORD, JD
    CROWLEY, WF
    ENDOCRINE REVIEWS, 1986, 7 (01) : 24 - 33
  • [5] Effectiveness and limitations of the use of the gonadotropin-releasing hormone agonist leuprolide acetate in the diagnosis of delayed puberty in males
    Lanes, R
    Gunczler, P
    Osuna, JA
    Palacios, A
    Carrillo, E
    Ramirez, X
    Garcia, C
    Paoli, M
    Villaroel, O
    HORMONE RESEARCH, 1997, 48 (01) : 1 - 4
  • [6] EFFECTS OF DANAZOL, GONADOTROPIN-RELEASING-HORMONE AGONIST, AND A COMBINATION OF DANAZOL AND GONADOTROPIN-RELEASING-HORMONE AGONIST ON EXPERIMENTAL ENDOMETRIOSIS
    SAKATA, M
    TERAKAWA, N
    MIZUTANI, T
    TANIZAWA, O
    MATSUMOTO, K
    TERADA, N
    SUDO, K
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (05) : 1679 - 1684
  • [7] INDUCTION OF PUBERTY BY PULSATILE GONADOTROPIN-RELEASING-HORMONE
    STANHOPE, R
    BROOK, CGD
    PRINGLE, PJ
    ADAMS, J
    JACOBS, HS
    LANCET, 1987, 2 (8558): : 552 - 555
  • [8] GONADOTROPIN-RELEASING-HORMONE AGONIST (NAFARELIN) TEST TO DIFFERENTIATE GONADOTROPIN-DEFICIENCY FROM CONSTITUTIONALLY DELAYED PUBERTY IN TEENAGE BOYS - A CLINICAL RESEARCH-CENTER STUDY
    GHAI, K
    CARA, JF
    ROSENFIELD, RL
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (10): : 2980 - 2986
  • [9] GONADOTROPIN-RELEASING-HORMONE DEFICIENCY IN MEN - DIAGNOSIS AND TREATMENT WITH EXOGENOUS GONADOTROPIN-RELEASING-HORMONE
    CROWLEY, WF
    WHITCOMB, RW
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (05) : 1752 - 1758
  • [10] GONADOTROPIN-RELEASING-HORMONE AGONIST AND LAPAROSCOPIC MYOMECTOMY
    DUBUISSON, JB
    LECURU, F
    FOULOT, H
    MANDELBROT, L
    DELAJOLINIERE, JB
    AUBRIOT, FX
    CLINICAL THERAPEUTICS, 1992, 14 : 51 - 56